Hemorheological Alterations and Oxidative Damage in Sickle Cell Anemia.

erythrocyte deformability erythrocyte membrane hemorheology oxidative damage sickle cell anemia

Journal

Frontiers in molecular biosciences
ISSN: 2296-889X
Titre abrégé: Front Mol Biosci
Pays: Switzerland
ID NLM: 101653173

Informations de publication

Date de publication:
2019
Historique:
received: 16 09 2019
accepted: 20 11 2019
entrez: 24 12 2019
pubmed: 24 12 2019
medline: 24 12 2019
Statut: epublish

Résumé

Sickle cell anemia (SCA) is the most common hereditary disorder of hemoglobin (Hb) characterized by a mutation in the β globin gene, which leads to synthesis of HbS a hemoglobin which, under hypoxic conditions, gels and leading to the sickling of the red blood cells (RBC). The dehydration of the RBC increases the concentration of the intracellular Hb with an increase in the internal viscosity and consequently a decrease in the erythrocyte deformability. Sickle red blood cells due to their difficulty to flow through the microcirculation cause frequent vaso-occlusive episodes, tissue ischemia, and infarctions. Moreover, the reduced RBC deformability causes cell fragility leading to hemolysis and recently a key role of hemolysis and oxidative stress in the development of vascular dysfunction has been demonstrated. The aim of this study was to evaluate the hemorheological profiles of patients with SCA in order to point out new indices of vascular impairment, and to characterize the membrane oxidative damage of sickled RBC. Blood viscosities, erythrocyte aggregation, and viscoelastic profiles of SCA patients were determined, and the RBC oxidative damage was investigated by comparing metabolic capability and RBC membrane proteins from SCA patients with and without transfusion dependence. The hemorheological profile of SCA subjects demonstrated high blood viscosity, increased RBC aggregation, and decreased RBC deformability. These impaired flow properties were associated with RBC membrane protein oxidation, with degradation of spectrin and increased membrane-bound globin. The comparison between SCA patients with and without transfusion dependence showed metabolic and structural RBC oxidative damage significantly different.

Identifiants

pubmed: 31867341
doi: 10.3389/fmolb.2019.00142
pmc: PMC6904369
doi:

Types de publication

Journal Article

Langues

eng

Pagination

142

Informations de copyright

Copyright © 2019 Caprari, Massimi, Diana, Sorrentino, Maffei, Materazzi and Risoluti.

Références

Chem Biol Interact. 1995 Mar 18;94(3):243-58
pubmed: 7820887
J Clin Invest. 1985 Jan;75(1):266-71
pubmed: 2578138
J Pediatr. 2018 Apr;195:228-235
pubmed: 29449005
Clin Hemorheol Microcirc. 2009;42(2):75-97
pubmed: 19433882
J Biol Chem. 1987 Nov 15;262(32):15666-72
pubmed: 3316203
J Thromb Haemost. 2016 Nov;14(11):2287-2297
pubmed: 27557753
Biochem Med Metab Biol. 1991 Feb;45(1):16-27
pubmed: 2015106
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063
Clin Lab Haematol. 1989;11(2):131-8
pubmed: 2548802
Br J Haematol. 2015 Mar;168(5):728-36
pubmed: 25316332
Thromb Haemost. 2017 Dec;117(12):2334-2345
pubmed: 29212121
Br J Haematol. 2014 Aug;166(4):601-6
pubmed: 24754710
Biochem J. 1986 Jul 1;237(1):265-9
pubmed: 3800879
Hematology. 2019 Dec;24(1):1-9
pubmed: 30010491
Br J Haematol. 2017 Aug;178(3):468-475
pubmed: 28466542
Br J Haematol. 1977 Feb;35(2):331-40
pubmed: 857853
Clin Chim Acta. 2015 Jan 15;439:50-7
pubmed: 25314938
PLoS One. 2013;8(2):e56759
pubmed: 23424675
Blood Cells Mol Dis. 2011 Mar 15;46(3):220-5
pubmed: 21334230
Lancet. 2017 Jul 15;390(10091):311-323
pubmed: 28159390
Microcirculation. 2004 Mar;11(2):209-25
pubmed: 15280093
J Lab Clin Med. 1979 Oct;94(4):542-8
pubmed: 479666
Br J Haematol. 2006 Jan;132(1):108-13
pubmed: 16371026
Front Physiol. 2018 May 11;9:332
pubmed: 29867516
Med Clin North Am. 2017 Mar;101(2):375-393
pubmed: 28189177
Acta Haematol. 1987;78(2-3):105-8
pubmed: 3120454
J Clin Invest. 1982 Dec;70(6):1253-9
pubmed: 6294138
J Pediatr (Rio J). 2016 Jul-Aug;92(4):394-9
pubmed: 27117632
Talanta. 2017 Nov 1;174:673-678
pubmed: 28738640
J Clin Invest. 1976 Oct;58(4):955-63
pubmed: 965498
Ann Ist Super Sanita. 2007;43(2):164-70
pubmed: 17634665
Sci Rep. 2017 Apr 21;7(1):1039
pubmed: 28432323
J Cell Physiol. 2008 Jan;214(1):145-52
pubmed: 17559077
Br J Haematol. 1981 Jul;48(3):435-44
pubmed: 7259992
Blood Rev. 2016 Mar;30(2):111-8
pubmed: 26341565
Talanta. 2016 Oct 1;159:425-432
pubmed: 27474327
Int J Angiol. 2018 Mar;27(1):35-38
pubmed: 29483764
Br J Haematol. 1980 Jan;44(1):87-92
pubmed: 7378296
Talanta. 2018 Jun 1;183:216-222
pubmed: 29567167
PLoS One. 2013 Jul 26;8(7):e68929
pubmed: 23922670
Lancet. 2010 Dec 11;376(9757):2018-31
pubmed: 21131035
Redox Biol. 2015 Dec;6:226-239
pubmed: 26285072
Blood Cells Mol Dis. 2014 Apr;52(4):230-5
pubmed: 24246527
Br J Haematol. 2014 May;165(4):564-72
pubmed: 24611951
Polymers (Basel). 2018 Jun 19;10(6):null
pubmed: 30966716

Auteurs

Patrizia Caprari (P)

National Centre for the Control and Evaluation of Medicine, IstitutoSuperiore di Sanità, Rome, Italy.

Sara Massimi (S)

National Centre for the Control and Evaluation of Medicine, IstitutoSuperiore di Sanità, Rome, Italy.

Loretta Diana (L)

National Centre for the Control and Evaluation of Medicine, IstitutoSuperiore di Sanità, Rome, Italy.

Francesco Sorrentino (F)

Thalassemia Unit, S. Eugenio Hospital, Rome, Italy.

Laura Maffei (L)

Thalassemia Unit, S. Eugenio Hospital, Rome, Italy.

Stefano Materazzi (S)

Department of Chemistry, Sapienza University of Rome, Rome, Italy.

Roberta Risoluti (R)

Department of Chemistry, Sapienza University of Rome, Rome, Italy.

Classifications MeSH